Chapter
The Healing Power of MDMA and Ketamine-Assisted Psychotherapy
08:02 - 18:46 (10:43)
Psychiatrist Dr. Will Van Derveer explains that the success of MDMA and ketamine-assisted psychotherapy is due to teaching patients to heal themselves, leading to long-lasting results for treatment-resistant PTSD.
Clips
The Capstone Campaign aimed to raise $30 million to complete phase three trials of MDMA, which is used in the treatment of PTSD, and was a significant challenge in the field of psychedelic science due to a lack of focus and funding until recent years.
08:02 - 10:38 (02:36)
Summary
The Capstone Campaign aimed to raise $30 million to complete phase three trials of MDMA, which is used in the treatment of PTSD, and was a significant challenge in the field of psychedelic science due to a lack of focus and funding until recent years.
ChapterThe Healing Power of MDMA and Ketamine-Assisted Psychotherapy
Episode#458: The Psychedelic News Hour: New Breakthroughs, Compound Comparisons and Warnings (Psilocybin/LSD/Ayahuasca/N,N-DMT/5-MeO-DMT), Treatment of Trauma, Scalable vs. Unscalable Approaches, Making Sense of “Bad” Trips, and Much More
PodcastThe Tim Ferriss Show
Psychiatrists are teaching patients how to heal themselves using therapies like MDMA and Ketamine Assisted Psychotherapy, which have been commended with breakthrough therapy designation by the FDA due to their low toxicity and incredible safety profiles, and can treat patients with PTSD, even those resistant to regular treatment.
10:38 - 18:46 (08:07)
Summary
Psychiatrists are teaching patients how to heal themselves using therapies like MDMA and Ketamine Assisted Psychotherapy, which have been commended with breakthrough therapy designation by the FDA due to their low toxicity and incredible safety profiles, and can treat patients with PTSD, even those resistant to regular treatment.